{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:12:31Z","timestamp":1792653151757,"version":"4.5.0"},"reference-count":27,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1136\/sextrans-2016-052768","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T02:15:14Z","timestamp":1478052914000},"page":"155-161","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":28,"title":["Self-administered interventions for anogenital warts in immunocompetent patients: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"93","author":[{"given":"Ricardo Niklas","family":"Werner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Westfechtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Dressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Nast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,11,1]]},"reference":[{"key":"key-10.1136\/sextrans-2016-052768-1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"key-10.1136\/sextrans-2016-052768-2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343:","author":"Higgins","year":"2011","journal-title":"BMJ."},{"key":"key-10.1136\/sextrans-2016-052768-3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"key-10.1136\/sextrans-2016-052768-4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence\u2014study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"key-10.1136\/sextrans-2016-052768-5","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence\u2014inconsistency","volume":"64","author":"Guyatt","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"key-10.1136\/sextrans-2016-052768-6","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence\u2014indirectness","volume":"64","author":"Guyatt","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"key-10.1136\/sextrans-2016-052768-7","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence\u2014imprecision","volume":"64","author":"Guyatt","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"key-10.1136\/sextrans-2016-052768-8","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence\u2014publication bias","volume":"64","author":"Guyatt","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"key-10.1136\/sextrans-2016-052768-9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/AAC.42.4.789","article-title":"Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts","volume":"42","author":"Beutner","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.1136\/sextrans-2016-052768-10","doi-asserted-by":"crossref","first-page":"806105","DOI":"10.1155\/2011\/806105","article-title":"Imiquimod 3.75% cream applied daily to treat anogenital warts: combined results from women in two randomized, placebo-controlled studies","volume":"2011","author":"Baker","year":"2011","journal-title":"Infect Dis Obstet Gynecol"},{"key":"key-10.1136\/sextrans-2016-052768-11","first-page":"277","article-title":"Imiquimod cream 2.5% and 3.75% applied once daily to treat external genital warts in men","volume":"96","author":"Rosen","year":"2015","journal-title":"Cutis"},{"key":"key-10.1136\/sextrans-2016-052768-12","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1346-8138.2004.tb00568.x","article-title":"Topical imiquimod 5% cream in external anogenital warts: a randomized, double-blind, placebo-controlled study","volume":"31","author":"Arican","year":"2004","journal-title":"J Dermatol"},{"issue":"(2 Pt 1)","key":"key-10.1136\/sextrans-2016-052768-13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0190-9622(98)70243-9","article-title":"Treatment of genital warts with an immune-response modifier (imiquimod)","volume":"38","author":"Beutner","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"key-10.1136\/sextrans-2016-052768-14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self-administered topical 5% imiquimod cream for external anogenital warts","volume":"134","author":"Edwards","year":"1998","journal-title":"Arch Dermatol"},{"key":"key-10.1136\/sextrans-2016-052768-15","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/517472","article-title":"A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod","volume":"178","author":"Tyring","year":"1998","journal-title":"J Infect Dis"},{"key":"key-10.1136\/sextrans-2016-052768-16","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(89)92282-4","article-title":"Patient-applied podofilox for treatment of genital warts","volume":"1","author":"Beutner","year":"1989","journal-title":"Lancet"},{"key":"key-10.1136\/sextrans-2016-052768-17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0002-9343(90)90424-C","article-title":"Double-blind randomized clinical trial of self-administered podofilox solution versus vehicle in the treatment of genital warts","volume":"88","author":"Kirby","year":"1990","journal-title":"Am J Med"},{"key":"key-10.1136\/sextrans-2016-052768-18","first-page":"105","article-title":"Self-treatment using 0.25%-0.50% podophyllotoxin-ethanol solutions against penile condylomata acuminata: a placebo-controlled comparative study","volume":"70","author":"Krogh","year":"1994","journal-title":"Genitourin Med"},{"key":"key-10.1136\/sextrans-2016-052768-19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.134.1.33","article-title":"Safety and efficacy of 0.5% Podofilox gel in the treatment of anogenital warts","volume":"134","author":"Tyring","year":"1998","journal-title":"Arch Dermatol"},{"key":"key-10.1136\/sextrans-2016-052768-20","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1365-2133.2008.08520.x","article-title":"Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial","volume":"158","author":"Stockfleth","year":"2008","journal-title":"Br J Dermatol"},{"key":"key-10.1136\/sextrans-2016-052768-21","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/AOG.0b013e3181719b60","article-title":"Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial","volume":"111","author":"Tatti","year":"2008","journal-title":"Obstet Gynecol"},{"key":"key-10.1136\/sextrans-2016-052768-22","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/j.1468-3083.2007.02441.x","article-title":"A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II\/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts","volume":"21","author":"Gross","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.1136\/sextrans-2016-052768-23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1258\/0956462961918400","article-title":"Topical treatment of venereal warts: a comparative open study of podophyllotoxin cream versus solution","volume":"7","author":"Claesson","year":"1996","journal-title":"Int J STD AIDS"},{"key":"key-10.1136\/sextrans-2016-052768-24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/sti.79.4.270","article-title":"Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts","volume":"79","author":"Lacey","year":"2003","journal-title":"Sex Transm Infect"},{"key":"key-10.1136\/sextrans-2016-052768-25","first-page":"387","article-title":"Topical treatment of genital warts in men, an open study of podophyllotoxin cream compared with solution","volume":"71","author":"Strand","year":"1995","journal-title":"Genitourin Med"},{"key":"key-10.1136\/sextrans-2016-052768-26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/OLQ.0b013e3181f68ebb","article-title":"Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts","volume":"38","author":"Komericki","year":"2011","journal-title":"Sex Transm Dis"},{"key":"key-10.1136\/sextrans-2016-052768-27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials: The consort statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2016-052768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T09:06:08Z","timestamp":1601111168000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2016-052768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,1]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,4,20]]},"published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.1136\/sextrans-2016-052768"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2016-052768","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,1]]}}}